BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12634753)

  • 1. Universities could gain from backing biotech.
    Kamb A
    Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
    [No Abstract]   [Full Text] [Related]  

  • 2. Northern England: rising star.
    Smaglik P
    Nature; 2003 Sep; 425(6956):430-3. PubMed ID: 14508497
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing university roles in the century of biotechnology.
    Meagher LR; Bolivar F
    Nat Biotechnol; 1998 Jul; 16(7):598-9. PubMed ID: 9661170
    [No Abstract]   [Full Text] [Related]  

  • 4. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 5. Danish biotech centre faces axe.
    Abbott A
    Nature; 2003 Mar; 422(6928):105. PubMed ID: 12634749
    [No Abstract]   [Full Text] [Related]  

  • 6. Upending the zeitgeist.
    Nature; 2006 Jun; 441(7093):572-3. PubMed ID: 16738631
    [No Abstract]   [Full Text] [Related]  

  • 7. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech jobs are still around despite the recent bumpy ride.
    Smaglik P; Smith A
    Nature; 2002 Jul; 418(6893):4-5. PubMed ID: 12097871
    [No Abstract]   [Full Text] [Related]  

  • 9. Cementing links between industry and the university.
    Jennings R
    Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
    [No Abstract]   [Full Text] [Related]  

  • 10. Berkeley dispute festers over biotech deal.
    Dalton R
    Nature; 1999 May; 399(6731):5. PubMed ID: 10331373
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular biology. Universities join the screening bandwagon.
    Kaiser J
    Science; 2008 Aug; 321(5890):766. PubMed ID: 18687935
    [No Abstract]   [Full Text] [Related]  

  • 12. Ontario.
    Hoag H
    Nature; 2005 Mar; 434(7033):676-7. PubMed ID: 15800632
    [No Abstract]   [Full Text] [Related]  

  • 13. No mistake in Berkeley's biotechnology deal.
    Hultin PG
    Nature; 2004 Oct; 431(7009):627. PubMed ID: 15470401
    [No Abstract]   [Full Text] [Related]  

  • 14. Primed for a biotech boom.
    Cyranoski D
    Nature; 2005 Oct; 437(7061):1060-2. PubMed ID: 16231417
    [No Abstract]   [Full Text] [Related]  

  • 15. Fresh horizons South Korea.
    Cyranoski D
    Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotechnology at Yale.
    Shiao S
    Yale J Biol Med; 2001; 74(3):197-9. PubMed ID: 11501716
    [No Abstract]   [Full Text] [Related]  

  • 17. China's unique position in discovery and preclinical research.
    Boutellier R; Ullman F
    Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
    [No Abstract]   [Full Text] [Related]  

  • 18. Harvesting biotechnology.
    Dennis C; Byrne N
    Nature; 2004 Jun; 429(6991 Suppl):1. PubMed ID: 15175703
    [No Abstract]   [Full Text] [Related]  

  • 19. Syngenta ends plant-research deal with Berkeley.
    Dalton R
    Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech blockbusters consolidate markets.
    Lawrence S
    Nat Biotechnol; 2006 Dec; 24(12):1466. PubMed ID: 17160033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.